News for NeuPath Health Inc. (NPTH.V)

Stephen Lemieux appointed as President of NeuPath Health Inc. (TSXV:NPTH), effective May 1, 2025. Lemieux brings over 20 years of experience in healthca

Fourth quarter total revenue of $18.9 million, up 12% year-over-year Q4 adjusted EBITDA(1) of $0.9 million, up 18% year-over-year, and our 24th consecutive quarte…

Arthrosamid can provide pain relief for knee osteoarthritis patients for up to four years after a single procedure NeuPath continues to accelerate growth as it ro…

NeuPath to report Q3 2024 results on November 14th before market open TORONTO — NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), is pleased to in…

TORONTO — NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatm…

TORONTO — NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain…

NeuPath Health Inc. reports Q4 adjusted EBITDA of C$0.8 million, revenue of C$16.8M, and a positive cash flow increase of over 100% YoY.

Fourth quarter total revenue of $16.8 million, up 4% year-over-year Adjusted EBITDA(1) of $0.8 million, our 20th consecutive quarter of positive adjusted…

Acquired the assets of SIBI Medical Inc., operating as the London Spine Institute, adding back, neck and spine specialists to enhance our care options for…

NeuPath Health Inc. reports Q3 2023 results with a GAAP EPS of $0.01 and revenue of $16.1M, representing a 5.7% YoY increase.

Delivered record second quarter total revenue of $17.1 million Adjusted EBITDA(1) of $1.0 million, our 18th consecutive quarter of positive adjusted EBITDA,…

TORONTO — NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain…